Transgene number-dependent, gene expression rate-independent rejection of Dd-, Kd-, or DdKd-transgened mouse skin or tumor cells from C57BL/6 (DbKb) mice

Microbiology and Immunology

Volumn 55, Issue 6, 2011, Pages 446-453

  Inoue, Yoshihiro ^a,b   Tashiro Yamaji, Junko ^a   Hayashi, Michihiro ^b   Kiyonari, Hiroshi ^c   Shimizu, Tetsunosuke ^a   Ibata, Minenori ^a   Yamana, Hidenori ^a   Kubota, Takahiro ^a   Tanigawa, Nobuhiko ^b   Yoshida, Ryotaro ^a  

^a Department of Physiology ^*  (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

MHC class I molecules; Skin; Transgene; Tumor

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOIMMUNITY; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CANCER GROWTH; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GENE EXPRESSION; GENETIC TRANSFECTION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; ISOTRANSPLANTATION; LYMPHOMA; MOUSE; MOUSE STRAIN; NONHUMAN; SKIN TRANSPLANTATION; STRAIN DIFFERENCE; TRANSGENE; TRANSGENIC MOUSE; TUMOR REJECTION;

ANIMALS; GENE EXPRESSION; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS; SKIN; TIME FACTORS;

MUS;

EID: 79957625726     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00337.x     Document Type: Article

References (42)

1. Mintz B., Silvers W.K. (1967) "Intrinsic" immunological tolerance in allophenic mice. Science 158: 1484-6.
2. Mintz B., Silvers W.K. (1970) Histocompatibility antigens on melanoblasts and hair follicle cells: Cell-localized homograft rejection in allophenic skin grafts. Transplantation 9: 497-505.
3. Ascher N.L., Ferguson R.M., Hoffman R., Simmons R.L. (1991) Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 1979; 27: 254-9.
4. Hall B.M. (1991) Cells mediating allograft rejection. Transplantation 51: 1141-51.
5. Alter B.J., Schendell D.J., Bach M.L., Bach F.H., Klein J., Stimpfling J.H. (1973) Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med 138: 1303-9.
6. Klein J., Hauptfeld M., Hauptfeld V. (1974) Evidence for a third, Ir-associated histocompatibility region in the H-2 complex of the mouse. Immunogenetics 1: 45.
7. Zijlstra M., Auchincloss H. Jr., Loring J.M., Chase C.M., Russell P.S., Jaenisch R. (1992) Skin graft rejection by β2-microglobulin-deficient mice. J Exp Med 175: 885-93.
8. + T lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 156: 4114-9.
9. + cells are essential for allorejection. J Exp Med 184: 2013-8.
10. Yoshida R., Takikawa O., Oku T., Habara-Ohkubo A. (1991) Mononuclear phagocytes: A major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc Natl Acad Sci USA 88: 1526-30.
11. Ushio Y., Yamamoto N., Sanchez-Bueno A., Yoshida R. (1996) Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol Immunol 40: 489-98.
12. Yoshida R., Matsuura A., Einaga K., Ushio Y., Yamamoto N., Yoneda Y. (1997) Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection site: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol Immunol 41: 149-59.
13. 2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J Immunol 159: 15-21.
14. Yamamoto N., Einaga-Naito K., Kuriyama M., Kawada Y., Yoshida R. (1998) Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 65: 818-25.
15. Yoshida R., Oku T., Takikawa O., Einaga-Naito K., Yoneda Y., Hirota R. (2000) Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts. Microbiol Immunol 44: 57-67.
16. Nomi H., Tashiro-Yamaji J., Yamamoto Y., Miura-Takeda S., Miyoshi-Higashino M., Takahashi T., Azuma H., Ueda H., Katsuoka Y., Kubota T., Yoshida R. (2007) Acute rejection of allografted, CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice. J Immunol 179: 2180-6.
17. Shimizu T., Tashiro-Yamaji J., Hayashi M., Inoue Y., Ibata M., Kubota T., Tanigawa N., Yoshida R. (2010) HLA-B62 as a possible ligand for the human homologue of mouse macrophage MHC receptor 2 (MMR2) on monocytes. Gene 454: 31-8.
18. d, in mice. Microbiol Immunol 50: 105-16.
19. d, in mice. Gene 384: 1-8.
20. Niwa H., Yamamura K., Miyazaki J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-9.
21. Gordon J.W., Scangos G.A., Plotkin D.J., Barbosa J.A., Ruddle F.H. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77: 7380-4.
22. Stephan D., Sun H., Lindahl K.F., Meyer E., Hämmerling G., Hood L., Steinmetz M. (1986) Organization and evolution of D region class I genes in the mouse major histocompatibility complex. J Exp Med 163: 1227-44.
23. d gene by T cells of the mouse. Immunogenetics 30: 156-61.
24. d histocompatibility antigen. Nucl Acid Res 11: 1567-77.
25. Katoh K., Takahashi Y., Hayashi S., Kondoh H. (1987) Improved mammalian vectors for high expression of G418 resistance. Cell Struct Funct 12: 575-80.
26. Loveland B.E., Hogarth P.M., Ceredic R., McKenzie I.F.C. (1981) Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 153: 1044-57.
27. Winn H.J. (1961) Immune mechanisms in homotransplantations. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol 86: 228-39.
28. Greene M.I., Fujimoto S., Sehon A.H. (1977) Regulation of the immune response to tumor antigens. III. Characterization of the thymic suppressor factor(s) produced by tumor-bearing host. J Immunol 119: 757-64.
29. Krist LF, Kerremans M, Koenen H, Blijleven N, Eestermans IL, Calame W, Meyer S, Beelen RH. (1995) Novel isolation and purification method permitting functional cytotoxicity studies of macrophages from milky spots in the greater omentum. J Immunol Methods 184: 253-61.
30. Yoshida R., Park S.W., Yasui H., Takikawa O. (1988) Tryptophan degradation in transplanted tumor cells undergoing rejection. J Immunol 141: 2819-23.
31. Larsen C.P., Steinman R.M., Witmer-Pack M., Hankins D.F., Morris P.J., Austyn J.M. (1990) Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172: 1483-93.
32. Sherman A.L., Chattopadhyay S. (1993) The molecular basis of allorecognition. Annu Rev Immunol 11: 385-402.
33. Lienert-Weidenbach K., Valiante N.M., Brown C., White C., Johnston-Dow L., McGinnis M., Krausa P., Lakes D.M., Wolf J.L., Blume K.G., Parham P. (1997) Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling. Biol Blood Marrow Transplant 3: 255-60.
34. b antigen. J Exp Med 173: 261-4.
35. Auchincloss H., Mayer T., Ghobrial R., Winn H.J. (1989) T-cell subsets, bm mutants, and the mechanisms of allogeneic graft rejection. Immunol Res 8: 149-64.
36. Brondz B.D., Egorov I.K., Drizlikh G.I. (1975) Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity. J Exp Med 141: 11-26.
37. Boem U., Klamp T., Groot M., Howard J.C. (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-95.
38. Saleem S., Konieczny B., Lowry R.P., Baddoura F.K., Lakkis F.G. (1996) Acute rejection of vascularized allografts in the absence of IFN [gamma]. Transplantation 62: 1908-11.
39. Jones N.D., Turvey S.E., Van Maurik A., Hara M., Kingsley C.I., Smith C.H., Mellor A.L., Morris P.J., Wood K.J. (2001) Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 166: 2824-30.
40. Sun J., Sheil A.G., Wang C., Wang L., Rokahr K., Sharland A., Jung S.E., Li L., McCaughan G.W., Bishop G.A. (1996) Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 62: 1725-30.
41. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., Miyake K. (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 198: 1035-42.
42. Corr M., Slanetz A.E., Boyd L.F., Jelonek M.T., Khilko S., al-Ramadi B.K., Kim Y.S., Maher S.E., Bothwell A.L., Margulies D.H. (1994) T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265: 946-9.